These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 16912509

  • 1. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
    Chaler EA, Rivarola MA, Guerci B, Ciaccio M, Costanzo M, Travaglino P, Maceiras M, Pagani S, Meazza C, Bozzola E, Barberi S, Bozzola M, Belgorosky A.
    Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone deficiency: new approaches to the diagnosis.
    Binder G.
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():535-7. PubMed ID: 22423512
    [Abstract] [Full Text] [Related]

  • 4. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F.
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [Abstract] [Full Text] [Related]

  • 5. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Dec; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 7. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I, Demirel F, Tepe D, Kara O, Koc N.
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [Abstract] [Full Text] [Related]

  • 8. Auxology-based cut-off values for biochemical testing of GH secretion in childhood.
    Binder G, Huller E, Blumenstock G, Schweizer R.
    Growth Horm IGF Res; 2011 Aug; 21(4):212-8. PubMed ID: 21665508
    [Abstract] [Full Text] [Related]

  • 9. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH, Wai YY, Van YH, Lo FS.
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [Abstract] [Full Text] [Related]

  • 10. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S, Pirazzoli P, Baronio F, Gennari M, Bal MO, Balsamo A, Gualandi S, Cicognani A.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [Abstract] [Full Text] [Related]

  • 11. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD.
    Lissett CA, Jönsson P, Monson JP, Shalet SM, KIMS International Board.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):773-8. PubMed ID: 14974921
    [Abstract] [Full Text] [Related]

  • 12. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 13. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Sep 23; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 14. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct 23; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep 23; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 16. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May 23; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul 23; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 18. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 23; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 19. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature.
    Hilczer M, Smyczynska J, Lewinski A.
    Endocr Regul; 2006 Sep 23; 40(3):69-75. PubMed ID: 17100548
    [Abstract] [Full Text] [Related]

  • 20. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J, Stawerska R, Hilczer M, Lewiński A.
    Exp Clin Endocrinol Diabetes; 2015 Apr 23; 123(4):209-14. PubMed ID: 25607339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.